IT1164626B - Procedimento per il ricupero di ifn-b umano da microorganismi produttori trasformati - Google Patents
Procedimento per il ricupero di ifn-b umano da microorganismi produttori trasformatiInfo
- Publication number
- IT1164626B IT1164626B IT47779/83A IT4777983A IT1164626B IT 1164626 B IT1164626 B IT 1164626B IT 47779/83 A IT47779/83 A IT 47779/83A IT 4777983 A IT4777983 A IT 4777983A IT 1164626 B IT1164626 B IT 1164626B
- Authority
- IT
- Italy
- Prior art keywords
- recovery
- procedure
- human ifn
- transformed
- producer microorganisms
- Prior art date
Links
- 238000000034 method Methods 0.000 title 1
- 244000005700 microbiome Species 0.000 title 1
- 238000011084 recovery Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/565—IFN-beta
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/353,360 US4450103A (en) | 1982-03-01 | 1982-03-01 | Process for recovering human IFN-β from a transformed microorganism |
Publications (2)
Publication Number | Publication Date |
---|---|
IT8347779A0 IT8347779A0 (it) | 1983-02-24 |
IT1164626B true IT1164626B (it) | 1987-04-15 |
Family
ID=23388775
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IT47779/83A IT1164626B (it) | 1982-03-01 | 1983-02-24 | Procedimento per il ricupero di ifn-b umano da microorganismi produttori trasformati |
Country Status (8)
Country | Link |
---|---|
US (1) | US4450103A (forum.php) |
EP (1) | EP0102989B1 (forum.php) |
JP (1) | JPS59500597A (forum.php) |
AU (1) | AU549721B2 (forum.php) |
CA (1) | CA1187013A (forum.php) |
DE (1) | DE3363647D1 (forum.php) |
IT (1) | IT1164626B (forum.php) |
WO (1) | WO1983003103A1 (forum.php) |
Families Citing this family (50)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4925919A (en) * | 1984-04-25 | 1990-05-15 | Roland Mertelsmann | Purified interleukin 2 |
US5702699A (en) * | 1982-09-23 | 1997-12-30 | Cetus Corporation | Process for the recovery of lipophilic proteins |
US4992271A (en) * | 1982-09-23 | 1991-02-12 | Cetus Corporation | Formulation for lipophilic IL-2 proteins |
US4853332A (en) * | 1982-10-19 | 1989-08-01 | Cetus Corporation | Structural genes, plasmids and transformed cells for producing cysteine depleted muteins of biologically active proteins |
JPS60118196A (ja) * | 1983-11-30 | 1985-06-25 | Takeda Chem Ind Ltd | インタ−フェロンの製造法 |
US4569790A (en) * | 1984-03-28 | 1986-02-11 | Cetus Corporation | Process for recovering microbially produced interleukin-2 and purified recombinant interleukin-2 compositions |
US4530787A (en) * | 1984-03-28 | 1985-07-23 | Cetus Corporation | Controlled oxidation of microbially produced cysteine-containing proteins |
US4908434A (en) * | 1984-04-25 | 1990-03-13 | Sloan-Kettering Institute For Cancer Research | Process for preparing purified interleukin-2 |
US4908433A (en) * | 1984-04-25 | 1990-03-13 | Sloan-Kettering Institute For Cancer Research | Uses of interleukin-2 |
DE3421302A1 (de) * | 1984-06-08 | 1985-12-12 | Hoechst Ag, 6230 Frankfurt | Verfahren zur isolierung und reinigung von (alpha)-interferonen |
US4572798A (en) * | 1984-12-06 | 1986-02-25 | Cetus Corporation | Method for promoting disulfide bond formation in recombinant proteins |
US5248769A (en) * | 1985-06-26 | 1993-09-28 | Cetus Oncology Corporation | Process for recovering refractile bodies containing heterologous proteins from microbial hosts |
US4748234A (en) * | 1985-06-26 | 1988-05-31 | Cetus Corporation | Process for recovering refractile bodies containing heterologous proteins from microbial hosts |
US4675387A (en) | 1985-07-26 | 1987-06-23 | E. I. Du Pont De Nemours And Company | Method for extracting protein with organic acid |
US4816440A (en) * | 1985-09-26 | 1989-03-28 | Cetus Corporation | Stable formulation of biologically active proteins for parenteral injection |
US5183746A (en) * | 1986-10-27 | 1993-02-02 | Schering Aktiengesellschaft | Formulation processes for pharmaceutical compositions of recombinant β- |
US5004605A (en) * | 1987-12-10 | 1991-04-02 | Cetus Corporation | Low pH pharmaceutical compositions of recombinant β-interferon |
ATE159260T1 (de) * | 1990-11-23 | 1997-11-15 | Roussel Uclaf | Verfahren zur herstellung eines proteins gehörend zu der klasse der cytokine, das mindestens eine intramolekulare disulfidbrücke enthält, durch oxidation bei einem ph-wert kleiner als 5.0 des entsprechenden rekombinanten reduzierten proteins |
DE4128319A1 (de) * | 1991-08-27 | 1993-03-04 | Bioferon Biochem Substanz | Neues rekombinantes human-ifn-beta, verfahren zu dessen herstellung und dieses enthaltende pharmazeutische zubereitungen |
FR2686899B1 (fr) * | 1992-01-31 | 1995-09-01 | Rhone Poulenc Rorer Sa | Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant. |
US6399296B1 (en) * | 1994-07-20 | 2002-06-04 | The General Hospital Corporation | Interaction trap systems for detecting protein interactions |
ATE268810T1 (de) * | 1995-12-21 | 2004-06-15 | Genzyme Corp | Methode zur zellyse |
US7026468B2 (en) * | 1996-07-19 | 2006-04-11 | Valentis, Inc. | Process and equipment for plasmid purification |
US7807822B2 (en) | 1996-08-01 | 2010-10-05 | Robert Bridenbaugh | Methods for purifying nucleic acids |
CA2348675A1 (en) | 1997-10-24 | 1999-05-06 | Warren Dang | Methods for preparing polynucleotide transfection complexes |
JPH11335392A (ja) | 1998-05-26 | 1999-12-07 | Hsp Kenkyusho:Kk | 可溶性タンパク質の回収方法 |
EP2213743A1 (en) * | 2000-04-12 | 2010-08-04 | Human Genome Sciences, Inc. | Albumin fusion proteins |
US20050100991A1 (en) * | 2001-04-12 | 2005-05-12 | Human Genome Sciences, Inc. | Albumin fusion proteins |
US20030143191A1 (en) * | 2001-05-25 | 2003-07-31 | Adam Bell | Chemokine beta-1 fusion proteins |
AR034749A1 (es) * | 2001-07-09 | 2004-03-17 | Schering Ag | Formulaciones de interferon beta humano |
KR101271635B1 (ko) * | 2001-12-21 | 2013-06-12 | 휴먼 게놈 사이언시즈, 인코포레이티드 | 알부민 융합 단백질 |
EP1463752A4 (en) * | 2001-12-21 | 2005-07-13 | Human Genome Sciences Inc | ALBUMIN FUSION PROTEINS |
CA2841097A1 (en) * | 2001-12-21 | 2003-07-24 | Human Genome Sciences, Inc. | Albumin and g-csf fusion proteins |
US7314746B2 (en) | 2002-09-13 | 2008-01-01 | Valentis, Inc. | Apparatus and method for preparative scale purification of nucleic acids |
CA2513213C (en) | 2003-01-22 | 2013-07-30 | Human Genome Sciences, Inc. | Albumin fusion proteins |
WO2005084303A2 (en) * | 2004-03-01 | 2005-09-15 | Enzon Pharmaceuticals, Inc. | Interferon-beta polymer conjugates |
GB2427374B (en) * | 2004-04-07 | 2009-02-25 | Waters Investments Ltd | Compositions and methods for separating enantiomers |
DE102004047189A1 (de) | 2004-09-29 | 2006-04-06 | Robert Bosch Gmbh | Sensor zur Ortung metallischer Objekte sowie Verfahren zur Auswertung von Messsignalen eines solchen Sensors |
US8188224B2 (en) | 2005-04-11 | 2012-05-29 | Savient Pharmaceuticals, Inc. | Variant forms of urate oxidase and use thereof |
PL2013225T3 (pl) * | 2006-04-12 | 2015-06-30 | Crealta Pharmaceuticals Llc | Oczyszczanie białek z zastosowaniem kationowego środka powierzchniowo czynnego |
CN101743018A (zh) * | 2006-12-19 | 2010-06-16 | 梅里麦克药品公司 | 甲胎蛋白和免疫调谐剂的共同施用以治疗多发性硬化 |
WO2009045553A1 (en) * | 2007-10-05 | 2009-04-09 | Barofold, Inc. | High pressure treatment of aggregated interferons |
EA022201B1 (ru) | 2008-04-11 | 2015-11-30 | Мерримак Фармасьютикалз, Инк. | Агент, способный связываться с опухолевой клеткой, содержащий линкер на основе hsa, и его применение |
CA2721870C (en) | 2008-04-21 | 2020-12-22 | Tissue Regeneration Therapeutics, Inc. | Genetically modified human umbilical cord perivascular cells for prophylaxis against or treatment of biological or chemical agents |
BRPI0921586A2 (pt) * | 2008-11-18 | 2019-09-24 | Merrimack Pharmaceuticals Inc | articuladores de albumina de soro humana e conjugados destes |
EP2440251A4 (en) * | 2009-06-09 | 2013-01-16 | Defyrus Inc | INTERFERON ADMINISTRATION FOR PROPHYLAXIS AGAINST PATHOGEN INFECTION OR TREATMENT OF PATHOGEN INFECTION |
AU2010265964B2 (en) | 2009-06-25 | 2014-09-18 | Horizon Therapeutics Usa, Inc. | Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during PEGylated uricase therapy |
US9345766B2 (en) | 2012-08-30 | 2016-05-24 | Merrimack Pharmaceuticals, Inc. | Combination therapies comprising anti-ERBB3 agents |
US12121566B2 (en) | 2019-01-30 | 2024-10-22 | Horizon Therapeutics Usa, Inc. | Methods for treating gout |
US12269875B2 (en) | 2023-08-03 | 2025-04-08 | Jeff R. Peterson | Gout flare prevention methods using IL-1BETA blockers |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4289689A (en) * | 1980-03-14 | 1981-09-15 | Hoffmann-La Roche Inc. | Preparation of homogeneous human fibroblast interferon |
AU538665B2 (en) * | 1979-10-30 | 1984-08-23 | Juridical Foundation, Japanese Foundation For Cancer Research | Human interferon dna |
GB2068970B (en) * | 1980-02-06 | 1983-06-22 | Searle & Co | Recombinant dna technique for the preparation of a protein resembling human interferon |
DE3005897A1 (de) * | 1980-02-16 | 1981-09-03 | Hoechst Ag, 6000 Frankfurt | Genprodukt eines hoeheren organismus aus einem dieses gen enhtaltenden mikroorganismus |
US4315852A (en) * | 1980-11-26 | 1982-02-16 | Schering Corporation | Extraction of interferon from bacteria |
-
1982
- 1982-03-01 US US06/353,360 patent/US4450103A/en not_active Expired - Lifetime
-
1983
- 1983-02-10 EP EP83900886A patent/EP0102989B1/en not_active Expired
- 1983-02-10 DE DE8383900886T patent/DE3363647D1/de not_active Expired
- 1983-02-10 AU AU13317/83A patent/AU549721B2/en not_active Expired
- 1983-02-10 WO PCT/US1983/000177 patent/WO1983003103A1/en active IP Right Grant
- 1983-02-10 JP JP58501024A patent/JPS59500597A/ja active Granted
- 1983-02-17 CA CA000421837A patent/CA1187013A/en not_active Expired
- 1983-02-24 IT IT47779/83A patent/IT1164626B/it active
Also Published As
Publication number | Publication date |
---|---|
CA1187013A (en) | 1985-05-14 |
IT8347779A0 (it) | 1983-02-24 |
EP0102989A1 (en) | 1984-03-21 |
DE3363647D1 (en) | 1986-07-03 |
AU1331783A (en) | 1983-10-18 |
AU549721B2 (en) | 1986-02-06 |
EP0102989B1 (en) | 1986-05-28 |
US4450103A (en) | 1984-05-22 |
WO1983003103A1 (en) | 1983-09-15 |
JPS59500597A (ja) | 1984-04-12 |
JPH0449999B2 (forum.php) | 1992-08-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IT1164626B (it) | Procedimento per il ricupero di ifn-b umano da microorganismi produttori trasformati | |
IT8421855A0 (it) | Apparecchio per l'applicazione di forza. | |
IT1194748B (it) | Composizioni farmaceutiche per il trattamento di osteopatie | |
DE3261760D1 (en) | Pharmaceutical compositions for the treatment of skin | |
RO88128A (ro) | Procedeu pentru prepararea n-fosfanometilglicinei | |
IT8420682A1 (it) | "Procedimento per il trattamento di articoli di maglieria" | |
IL70269A (en) | Composition for the treatment of arthritis comprising an azagermaspirodecane derivative | |
IT8348888A0 (it) | Procedimento per la fabbricazione di cuscinetti flangiati | |
IT1159815B (it) | Composizione medicinale per il trattamento di certe neurovirosi | |
IT1165797B (it) | Procedimento di preparazione di alchilangelicine esenti da psoraleni ed alchilangolicine ottenute col procedimento | |
IT1169421B (it) | Procedimento per la preparazione di benzen-derivati | |
IT8348372A0 (it) | Procedimento per la preparazione di tio-bisfenoli | |
IT1164613B (it) | Procedimento per la produzione di ditiazol-disolfuri | |
IT1203646B (it) | Procedimento per la preparazione di cloroacetanilidi sostituite | |
IT8347756A0 (it) | Procedimento per la purificazione di acetone | |
IT8148624A0 (it) | Procedimento per la purificazione di 2-mercaptobenzotiazolo | |
IT1197635B (it) | Procedimento per la preparazione di 3-idrossi-benzo-diezepinoni | |
IT8423757A1 (it) | Procedimento per la fabbricazione di poltacetilene | |
IT1171888B (it) | Procedimento per la produzione di acciaio inossidabile | |
IT8368287A0 (it) | Procedimento per la riconciatura di pellami | |
FR2543957B1 (fr) | Procede de preparation de la bacampicilline | |
RO86085A2 (ro) | Procedeu pentru sinteza tribloccopolimerilor butadien-stirenici elastomeri termoplastici | |
RO86086A2 (ro) | Procedeu pentru sinteze bloccopolimerilor elastomeri butadien-stirenici | |
IT8366701A0 (it) | Procedimento per la preparazione di esteri tioncarbammici | |
IT8366713A0 (it) | Procedimento per la preparazione di esteri trioncarbammici |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
TA | Fee payment date (situation as of event date), data collected since 19931001 |
Effective date: 19970227 |